Shirai K - Search Results

1

Evaluation of blood pressure control using a new arterial stiffness parameter, cardio-ankle vascular index (CAVI).

Shirai K, Utino J, Saiki A, Endo K, Ohira M, Nagayama D, Tatsuno I, Shimizu K, Takahashi M, Takahara A. Shirai K, et al. Curr Hypertens Rev. 2013 Feb;9(1):66-75. doi: 10.2174/1573402111309010010. Curr Hypertens Rev. 2013. PMID: 23807874 Free PMC article. Review.

2

[Relationship between insulin resistance and oxidative stress in vivo].

Hitsumoto T, Iizuka T, Takahashi M, Yoshinaga K, Matsumoto J, Shimizu K, Kaku M, Sugiyama Y, Sakurai T, Aoyagi K, Kanai M, Noike H, Ohsawa H, Watanabe H, Shirai K. Hitsumoto T, et al. Among authors: shirai k. J Cardiol. 2003 Sep;42(3):119-27. J Cardiol. 2003. PMID: 14526661 Japanese.

3

Reduction of visceral adiposity after operation in a subject with insulinoma.

Saiki A, Miyashita Y, Wakabayashi M, Kameda N, Shirai K. Saiki A, et al. Among authors: shirai k. J Atheroscler Thromb. 2004;11(4):209-14. doi: 10.5551/jat.11.209. J Atheroscler Thromb. 2004. PMID: 15356380 Free article.

4

[A relationship between insulin resistance and reduction in oxidative stress in vivo by atorvastatin].

Hitsumoto T, Iizuka T, Takahashi M, Nakamura K, Shimizu K, Satoh S, Sugiyama Y, Sakurai T, Noike H, Ohsawa H, Watanabe H, Shirai K. Hitsumoto T, et al. Among authors: shirai k. J Cardiol. 2004 Dec;44(6):233-42. J Cardiol. 2004. PMID: 15638221 Japanese.

5

Atorvastatin and pravastatin elevated pre-heparin lipoprotein lipase mass of type 2 diabetes with hypercholesterolemia.

Endo K, Miyashita Y, Saiki A, Oyama T, Koide N, Ozaki H, Otsuka M, Ito Y, Shirai K. Endo K, et al. Among authors: shirai k. J Atheroscler Thromb. 2004;11(6):341-7. doi: 10.5551/jat.11.341. J Atheroscler Thromb. 2004. PMID: 15644588 Free article. Clinical Trial.

6

Pitavastatin enhanced lipoprotein lipase expression in 3T3-L1 preadipocytes.

Saiki A, Murano T, Watanabe F, Oyama T, Miyashita Y, Shirai K. Saiki A, et al. Among authors: shirai k. J Atheroscler Thromb. 2005;12(3):163-8. doi: 10.5551/jat.12.163. J Atheroscler Thromb. 2005. PMID: 16020917 Free article.

7

Enhancement of serum lipoprotein lipase mass levels by intensive insulin therapy.

Miyashita Y, Ebisuno M, Ohhira M, Endoh K, Saiki A, Koide N, Ohtsuka M, Oyama T, Shirai K. Miyashita Y, et al. Among authors: shirai k. Diabetes Res Clin Pract. 2006 Apr;72(1):61-7. doi: 10.1016/j.diabres.2005.09.016. Epub 2006 Jan 30. Diabetes Res Clin Pract. 2006. PMID: 16446009

8

The angiotensin II receptor antagonist valsartan enhances lipoprotein lipase mass in preheparin serum in type 2 diabetes with hypertension.

Saiki A, Ohira M, Endo K, Koide N, Oyama T, Murano T, Miyashita Y, Shirai K. Saiki A, et al. Among authors: shirai k. Diabetes Res Clin Pract. 2006 Dec;74(3):242-8. doi: 10.1016/j.diabres.2006.04.004. Epub 2006 May 19. Diabetes Res Clin Pract. 2006. PMID: 16713009 Clinical Trial.

9

The role of pitavastatin-enhanced lipoprotein lipase expression in 3T3-L1 preadipocytes.

Saiki A, Miyashita Y, Shirai K. Saiki A, et al. Among authors: shirai k. J Atheroscler Thromb. 2006 Apr;13(2):122. doi: 10.5551/jat.13.122. J Atheroscler Thromb. 2006. PMID: 16733301 Free article. No abstract available.

10

Relationship between preheparin lipoprotein lipase mass concentration in serum and bare metal stent restenosis.

Hitsumoto T, Takahashi M, Iizuka T, Shirai K. Hitsumoto T, et al. Among authors: shirai k. J Cardiol. 2006 Aug;48(2):65-73. J Cardiol. 2006. PMID: 16948449

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,243 results

Search Page

Filters